Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer

By      

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 1246-1250

Spandidos Publications

Access to resources Recommend Favorite

Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2581-2586

Spandidos Publications

Access to resources Recommend Favorite

Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value

By Kempkensteffen Carsten   Hinz Stefan   Christoph Frank   Krause Hans   Magheli Ahmed   Schrader Mark   Schostak Martin   Miller Kurt   Weikert Steffen  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 543-550

Springer Publishing Company

Access to resources Recommend Favorite

JNK1mediated phosphorylation of Smac/DIABLO at the serine 6 residue is functionally linked to its mitochondrial release during TNFα­induced apoptosis of HeLa cells

By  

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3205-3210

Spandidos Publications

Access to resources Recommend Favorite

Smac mimeticinduced caspaseindependent necroptosis requires RIP1 in breast cancer

By Jin Gongsheng   Lan Yadong   Han Fusheng   Sun Yiming   Liu Zhe   Zhang Mingliang   Liu Xianfu   Zhang Xiaojing   Hu Jianguo   Liu Hao   Wang Benzhong  

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 359-366

Spandidos Publications

Access to resources Recommend Favorite